At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps can provide the best returns over the long term due to the fact that these companies are less efficiently priced and are usually under the radars of mass-media, analysts and dumb money. This is why we follow the smart money moves in the small-cap space.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) investors should be aware of an increase in hedge fund interest in recent months. CCRN was in 20 hedge funds’ portfolios at the end of the third quarter of 2015. There were 16 hedge funds in our database with CCRN positions at the end of the previous quarter. At the end of this article we will also compare CCRN to other stocks including Ultratech, Inc. (NASDAQ:UTEK), MFS Multimarket Income Trust (NYSE:MMT), and GSI Group Inc. (USA) (NASDAQ:GSIG) to get a better sense of its popularity.
Keeping this in mind, we’re going to take a gander at the new action encompassing Cross Country Healthcare, Inc. (NASDAQ:CCRN).
How have hedgies been trading Cross Country Healthcare, Inc. (NASDAQ:CCRN)?
Heading into Q4, a total of 20 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 25% from one quarter earlier. With the smart money’s positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their holdings considerably (or already accumulated large positions).
According to Insider Monkey’s hedge fund database, Camber Capital Management, managed by Stephen DuBois, holds the most valuable position in Cross Country Healthcare, Inc. (NASDAQ:CCRN). Camber Capital Management has a $20.3 million position in the stock, comprising 1.7% of its 13F portfolio. On Camber Capital Management’s heels is Millennium Management, managed by Israel Englander, which holds a $14.3 million position; less than 0.1% of its 13F portfolio is allocated to the stock. Remaining peers that are bullish contain Richard Driehaus’ Driehaus Capital, Columbus Circle Investors and Lee Munder’s Lee Munder Capital Group.